Pazopanib Impurity 34

N° de SZ CAT:	SZ-P013050
Número CAS	NA
Mol.F.	C25H22N10O
Peso Molecular	478.5
Status de Fatura	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

Nome Químico: 4-((2,3-Dimethyl-2H-indazol-6-yl)(4-((2-methyl-2H-indazol-5-yl)amino)pyrimidin-2-yl)amino)pyrimidin-2-ol

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: OC1=NC=CC(N(C2=CC3=NN(C)C(C)=C3C=C2)C4=NC=CC(NC5=CC6=CN(C)N=C6C=C5)=N4)=N1

Analytical control of process impurities in Pazopanib hydrochloride by impurity fate mapping
Yan Li 1, David Q Liu, Shawn Yang, Ravinder Sudini, Michael A McGuire, Dharmesh S Bhanushali, Alireza S Kord
J Pharm Biomed Anal. 2010 Aug 1;52(4):493-507.

Determination and characterization of process impurities in pazopanib hydrochloride drug substance
musty sharada, ravichandra babu
Int J Pharm Pharm Sci, Vol 8, Issue 4, 97-102

Characterization of forced degradation products of pazopanib hydrochloride by UHPLC‐Q‐TOF/MS and in silico toxicity prediction
Prinesh N. Patel Pradipbhai D. Kalariya Mahesh Sharma Prabha Garg M. V. N Kumar Talluri S. Gananadhamu R. Srinivas
Journal of mass spectrometry Volume50, Issue7 July 2015 Pages 918-928

Development and validation of a stability indicating RP-HPLC method for the determination of Pazopanib in bulk drug and its pharmaceutical dosage form
Kishore Kumar Reddy Y, J. Raveendra Reddy and N. Devanna
J. Chem. Pharm. Res., 2015, 7(9):127-132

Validated RP-HPLC Method Development of Pazopanib in Bulk and its Pharmaceutical Dosage Form
Kiran Kumar Buralla, and Varadarajan Parthasarathy
Pharmaceutical Methods,2020,11,1,21-24.

Pazopanib Impurity 34 is chemically 4-((2,3-Dimethyl-2H-indazol-6-yl)(4-((2-methyl-2H-indazol-5-yl)amino)pyrimidin-2-yl)amino)pyrimidin-2-ol. Pazopanib Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Pazopanib Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pazopanib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.